June 2016 VOL 7, NO 5

June 2016 VOL 7, No 5

Letters from Lillie

Journal of Oncology Navigation & Survivorship: Expanding to Meet the Needs of Navigators

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Dear Navigators, It is my great pleasure to welcome you to this issue of JONS, the official publication of the Academy of Oncology Nurse & Patient Navigators (AONN+). The Academy [ Read More ]

Interview with the Innovators

Oncology Nurse Navigators: A Growing Trend in Oncology Practices Proving to Play a Critical Role in Patient Care

An Interview with Lillie D. Shockney, RN, BS, MAS, of Johns Hopkins University

The terms “nurse navigator,” “patient navigator,” and “lay navigator” are slowly becoming part of the vernacular in oncology circles. In turn, nurse navigation is evolving into its own distinct field [ Read More ]

Original Research

The Impact of Patient Navigation in Low-Dose Computed Tomography Lung Screening

Kristi M. Griffith, MSN, RN, CHPN; Nora J. Barrett, BSN, RN, OCN; Kristi L. Case, MS, CHW; Susan W. Dahlin, BSN, RN, OCN; Stacey L. Webb, MPA-HCA, BSN, RN 

Background: The results from the National Lung Cancer Screening Trial in 2012 showed a 20% relative decrease in mortality with the use of annual low-dose computed tomography (LDCT) lung scans [ Read More ]

Oncology Navigation Certification

Certification: A Win/Win for Navigators, Employers, and Patients

As healthcare changes, and the value of care becomes a deciding factor for payment, the need for demonstrated clinical excellence grows. The Academy recognizes that for oncology navigators to excel [ Read More ]

Learning Guide

Overview of Operations Management

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Operations management, according to Wikipedia, is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. [ Read More ]

Learning Guide

Nurse Navigator Certification Learning Guide – Coordination of Care

Cheryl Bellomo, MSN, RN, OCN 

The scope of navigation has evolved from the Freeman model of community outreach and prevention to spanning the entire continuum of care for oncology patients. The current navigation model was [ Read More ]

Clinical Trials Tracker

Select Ongoing Trials Currently Enrolling Patients with Kidney Cancers

The following are a selection of key clinical trials that are currently recruiting patients for inclusion in investigations of new therapies or new combinations of available therapies for patients with [ Read More ]

Multidisciplinary Head and Neck Cancer Symposium

Immunotherapy: Separating Facts from Fiction

 

Response is a poor outcome measure of immunotherapy, according to Tanguy Seiwert, MD, who addressed this and other concerning issues in immunotherapy at the 2016 Multidisciplinary Head and Neck Cancer [ Read More ]

ASCO Quality Care Symposium

An Update on CancerLinQ—ASCO’s “Big-Data” Cancer Database

 

CancerLinQ is a powerful database containing vast amounts of usable, searchable, real-world cancer information, created by oncologists, for oncologists, to improve the quality of patient care. A national initiative inspired [ Read More ]

National Comprehensive Cancer Network

Immunotherapy Takes Center Stage in NCCN Advanced Melanoma Guideline

 

The revised guideline (Version 2.2016) for the management of advanced melanoma, released by the National Comprehensive Cancer Network (NCCN), shows increasing appreciation for the use of immune checkpoint inhibitors and [ Read More ]

National Comprehensive Cancer Network

New MM Guideline Expands Patients Eligible for Treatment

 

The population of patients with multiple myeloma (MM) who are eligible for therapy has been expanded to asymptomatic patients with certain features under the most recent National Comprehensive Cancer Network [ Read More ]

National Comprehensive Cancer Network

Panel Examines Effects of Healthcare Policy in an Election Year

 

The chances for further policy in healthcare during an election year are minimal, said panelists during a roundtable discussion at the National Comprehensive Cancer Network 21st Annual Conference. The exception [ Read More ]

National Comprehensive Cancer Network

Test for EGFR Mutation in All Patients with NSCLC

Matching Treatment to Molecular Alteration Yields Best Outcomes

 

Tyrosine kinase inhibitors (TKIs) are the mainstay of treatment for patients with EGFR mutation–positive non–small cell lung cancer (NSCLC), according to the most recent guideline on management of NSCLC issued [ Read More ]

Society of Gynecologic Oncology

Mutation Testing Encouraged for All Ovarian Cancer Patients

 

All women with ovarian cancer should have the option of genetic testing, regardless of tumor histology, investigators in a retrospective, tissue-based analysis of a randomized trial concluded. Tumors with defects [ Read More ]

Society of Gynecologic Oncology

Genomic Instability Score Predicts Survival in Ovarian Cancer

 

A higher score on a composite index of homologous recombination deficiency (HRD) correlated with improved progression-free survival (PFS) and overall survival (OS) in ovarian cancer treated with platinum-containing chemotherapy, results [ Read More ]

American Association for Cancer Research

Biologic Agents and Cardiac Toxicity Among Patients with Hematologic Malignancies

 

Targeted therapies used to treat hematologic malignancies can cause unintended cardiac toxicity in some patients and can lead to cardiac-related mortality, according to study results presented at the American Association [ Read More ]